2024-03-14 13:35:05
A sudden change in the A-share market. Two leading stocks worth hundreds of billions plummeted, triggering market turbulence and a fierce battle between long and short was imminent.
Financial World 2024-03-14 21:35:05
On March 14, the A-share market experienced violent fluctuations, and the three major indexes collectively fell slightly. Fii, the leading server industry, fell sharply once more today following yesterday’s flash crash. At the same time, stimulated by the news of the “Exposure Draft on the Implementation Plan for Supporting the Development of Innovative Drugs across the Whole Chain”, the Hong Kong A-share innovative drug sector once made a strong advance in early trading, but was subsequently affected by overseas bad news. The pharmaceutical sector fell behind WuXi AppTec. , WuXi Biologics and other heavyweight stocks fell sharply. Market sentiment has become cautious once more, and the game between long and short parties has further intensified.
The continued decline of Industrial Fii has aroused market concerns. As one of the leading stocks in the technology sector, Industrial Fii’s two-day plunge has aroused widespread market concern. Since its high in August last year, the stock has fallen more than 40%, wiping out nearly 150 billion yuan in market value. Fii’s sudden change of face reflects that the market’s confidence in technology stocks is gradually weakening. Against the background of declining demand for technology products due to slowing global economic growth, the high valuation bubble of technology stocks is gradually being punctured, and investors need to re-examine their true value.
Pharmaceutical stocks have suffered a major negative blow, and pharmaceutical stocks have always been favored by funds. However, the recent performance of pharmaceutical stocks has surprised investors. First, WuXi AppTec was “expelled” from the US BIO organization, and then there were rumors that the National Medical Insurance Bureau would significantly reduce the price of innovative drugs. Although the relevant rumors have not yet been officially confirmed, they are enough to trigger the spread of panic in the market. The sharp correction in pharmaceutical stocks reflects that policy uncertainty has become an important factor affecting the development of the industry. In the field of innovative drugs, although Chinese companies have made great progress, they still face multiple challenges such as patents and pricing. In the future, investment opportunities in pharmaceutical stocks still need to be carefully selected, and blindly chasing high prices may pay a heavy price.
Overall, the volatility of the A-share market is increasing amid the complex and ever-changing external environment. Investors need to remain rational, carefully evaluate the risk-return ratio, and allocate assets reasonably. For high-quality leading stocks, you can take advantage of adjustment opportunities to gradually deploy; while for high-valued stocks that have experienced large gains in the early stage, you need to be more vigilant and take profits when appropriate. Only by continuously improving your professional level and striving to grasp the pulse of the market can you achieve long-term and stable returns in the turbulent A-share market.
Warning from the financial community: The content, data and tools in this article do not constitute any investment advice and are for reference only and do not have any guiding role. The stock market is risky, so be cautious when investing!
1710443046
#sudden #change #Ashare #market #leading #stocks #worth #hundreds #billions #plummeted #triggering #market #turmoil #fierce #battle #long #short #break #Mobile #Financial #Industry
